Filters

Paliperidone palmitate manufacturers

Filters

Filters

Filters , active

Country of origin : China

paliperidone palmitate

Injection 75 mg, 100 mg, 150 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA
Manufacturer #1937

paliperidone palmitate

Suspension for injection 39 mg/0.25 ml, 78 mg/0.5 ml, 117 mg/0.75 ml, 156 mg/1 ml, 234 mg/1.5 ml, 351 mg/2.25 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA
Manufacturer #860

A pharmaceutical manufacturer focused on the research, development and production of innovative pharmaceutical products across key therapeutic areas including central nervous system, oncology, cardiovascular and metabolism. The company operates a global network that supports development, manufacturing and international distribution, supplying pharmaceutical products to more than 80 countries across major regulated markets worldwide.

paliperidone palmitate

Suspension for injection 25 mg/0.25 ml, 50 mg/0.5 ml, 75 mg/0.75 ml, 100 mg/ml, 150 mg/1.5 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
FDA
Manufacturer #17216

Global developer of innovative drugs in oncology, metabolic, autoimmune, and cardiovascular diseases, with 14 in-house products and multiple partnerships. Over 5,000 R&D staff across global centers and strong IP, clinical pipeline, and high-standard manufacturing.

Manufacturer usually replies in 41 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.